Read + Share
Amedeo Smart
Independent Medical Education
Kochar BD, Cheng D, Cai T, Ananthakrishnan AN, et al. Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2022;67:5206-5212.PMID: 35113275
Email
LinkedIn
Facebook
Twitter
Privacy Policy